221 related articles for article (PubMed ID: 11603004)
1. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
4. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
5. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ
Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
[TBL] [Abstract][Full Text] [Related]
10. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma.
Boucher E; Corbinais S; Rolland Y; Bourguet P; Guyader D; Boudjema K; Meunier B; Raoul JL
Hepatology; 2003 Nov; 38(5):1237-41. PubMed ID: 14578862
[TBL] [Abstract][Full Text] [Related]
12. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.
Raoul JL; Messner M; Boucher E; Bretagne JF; Campion JP; Boudjema K
Br J Surg; 2003 Nov; 90(11):1379-83. PubMed ID: 14598418
[TBL] [Abstract][Full Text] [Related]
13. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
[No Abstract] [Full Text] [Related]
14. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV
Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
16. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
19. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome.
Lambert B; Praet M; Vanlangenhove P; Troisi R; de Hemptinne B; Gemmel F; Van Vlierberghe H; Van de Wiele C
Cancer Biother Radiopharm; 2005 Apr; 20(2):209-14. PubMed ID: 15869457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
